Long-term Safety and Tolerability of AFFITOPE AD02

Affiris

Status: Completed

Conditions: Alzheimer's Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT00711321

EudraCT 2008-002764-33

Affiris 004

Details and patient eligibility

About

The purpose of this study is to evaluate the long-term tolerability and -safety of AFFITOPE AD02 applied during AFFiRiS 002

Enrollment: 23 patients

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Written informed consent signed and dated by patient and caregiver
• Patients having participated in AFF002 and having received at least 1 vaccination with AFFITOPE AD02
• Availability of a partner/caregiver knowing the patient and being able to accompany the patient to the visits

Exclusion criteria

• Patients having received no vaccination with AFFITOPE AD02
• History of questionable compliance to visit schedule, patients not expected to finish the clinical trial

Trial design

23 participants in 2 patient groups

2

Description:

AFFITOPE AD02 with adjuvant

1

Description:

AFFITOPE AD02 without adjuvant